ECM
MRNA icon

Eisler Capital Management’s Moderna MRNA Stock Holding History

Eisler Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.81M Sell
226,100
-25,000
-10% -$697K 0.03% 313
2025
Q2 		$6.93M Buy
251,100
+200,000
+391% +$5.27M 0.04% 326
2025
Q1 		$1.45M Buy
51,100
+31,100
+156% +$1.1M 0.01% 665
2024
Q4 		$840K Buy
+20,000
New +$956K ﹤0.01% 701

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Eisler Capital Management's MRNA Position: Q3 2025 in Review

Eisler Capital Management increased its Moderna (MRNA) stake by 2.4% in Q3 2025, buying an estimated $63.3K and bringing the position to 97,399 shares worth $2.5M. The position accounts for 0.01% of the portfolio, ranked #460.

Eisler Capital Management first reported a position in MRNA in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.63M in Q2 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Eisler Capital Management held 97,399 shares of Moderna worth $2.5M as of Q3 2025.
  • Eisler Capital Management bought 2,268 Moderna shares in Q3 2025, an estimated $63.3K.
  • Moderna made up 0.01% of Eisler Capital Management's portfolio in Q3 2025, its #460 holding.
  • Eisler Capital Management first reported a position in Moderna in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's Moderna position peaked at $2.63M in Q2 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.